Absolute Game Changer! New Henry Ford Study Shows Hydroxychloroquine Cut COVID-19 Deaths in Half!

By Don Rosenberg, 7/3/2020

An extensive, peer-reviewed study* of 2,541 patients, just released by the Henry Ford Health System, shows hydroxychloroquine, administered in the first 24-48 hours after hospital admission, cuts death rates from COVID-19 in half, from 26.4% with no drug, to 13.5% using hydroxychloroquine alone. There were no heart-related side effects. The results correlate with early studies done in other countries that showed similar effectiveness. Report from Fox News.

Recent reports that hydroxychloroquine is ineffective in treating COVID-19, led to the FDA revoking its Emergency Use Authorization* on June 15th. Its use was then banned by the FDA for everything except clinical trials.*

Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, co-authored the study with Henry Ford epidemiologist Dr. Samia Arshad. “We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring. Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.”

An ongoing battle has been raging between remdesivir and hydroxychloroquine to be the top treatment for COVID-19.

In early June, remdesivir was touted throughout the media, the FDA and the medical community as the “next big drug” after studies showed it reduced hospital time by 35%. But there were no indications that it increased survival rates.*

The latest media panic is the “alarming rise in new COVID-19 cases,” leading to reopening plans being reversed across the country. But if you go to https://www.statnews.com/feature/coronavirus/covid-19-tracker/, you’ll see that while reports of new cases are way up, deaths have remained steady at around 700 per day, with the high being 2,350 at the end of April. This is because new rules rolled out in June started adding “probable” cases to the totals, with multiple tests of the same patients counting as new cases.*

The death rate has also been inflated the same way, as people who die for any reason who either tested positive for COVID-19 at time of death, or who could be categorized as “probable” cases, now list cause of death as COVID-19.

The 120,000 questions are “Why are these numbers being inflated?” and “Why was hydroxychloroquine quashed, while remdesivir was promoted?”

 

Sad to say, the only logical answer is money, big money.

Hydroxychloroquine costs about 50¢ per tablet,* while remdesivir is $3,100 per treatment.*

Need we say more?

Let’s do some math. The potential profit for the pharmaceutical industry could be $2 Billion, if you assume the pandemic is not over, and another 120,000 people would die from COVID-19. If the hospitalized death rate was 20%, that’s 640,000 potential patients at $3,100 each, or $1,984,000,000. Use of remdesivir worldwide could total $10 Billion.

The hospital industry stands to make even more money by continuing the panic and treating with remdesivir. Using the same math as above, US hospitals would earn $25 Billion treating 640,000 patients at $39,000 per patient.*

I have no idea how accurate those estimates are, but we all know the big profit potential from expensive drug treatments and upcoming vaccines (estimated to bring in $10 billion per year.)

Compare that to sending patients home with a $10 bottle of hydroxychloroquine pills, and you have the picture.

 

If we can burst through the media hype bubble for remdesivir and against hydroxychloroquine, the implications for the COVID-19 pandemic are immediate and clear…

COVID-19 can be treated. Deaths can be cut in half or even more. Infections may be preventable in advance.

Anyone in the media, the medical profession, FDA or Congress, who says HCQ is ineffective or remdesivir is a worthwhile treatment is squarely in the pocket of Big Pharma, period.

Mask use is not needed since they don’t work.

Schools can be reopened in the fall, especially since kids don’t get it.

All businesses can be reopened immediately and they can decide what precautions they want to take.

All restrictions on public gatherings and religious services should be lifted immediately.

*Sources…

https://video.foxnews.com/v/6169019606001

https://www.henryford.com/news/2020/07/hydro-treatment-study

https://www.worldpharmanews.com/gilead/5287-gilead-announces-results-from-phase-3-trial-of-remdesivir-in-patients-with-moderate-covid-19

https://www.uspharmacist.com/article/covid19-patients-are-65-more-likely-to-improve-after-5-days-of-remdesivir

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-warns-newly-discovered-potential-drug-interaction-may-reduce

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and

https://www.startribune.com/daily-coronavirus-cases-in-united-states-at-all-time-high-as-numbers-rise-in-40-of-50-states/571598762/

https://www.npr.org/sections/health-shots/2020/06/29/884648842/remdesivir-priced-at-more-than-3-100-for-a-course-of-treatment

https://reopencentral.com/editorials/they-are-lying-with-statistics/

https://www.statnews.com/feature/coronavirus/covid-19-tracker/

https://aapsonline.org/hcqsuit/

https://www.healthleadersmedia.com/finance/fact-check-hospitals-get-paid-more-if-patients-listed-covid-19-ventilators

https://www.barrons.com/articles/a-covid-19-vaccine-could-be-worth-billions-for-moderna-and-its-rivals-51589902769

https://reopencentral.com/news/why-masks-dont-work/

Spread the word. Share this post!

Admin

About the Author

Leave a Reply

%d bloggers like this: